Results 91 to 100 of about 275,056 (297)

The disruptive effects of COPD exacerbation-associated factors on epithelial repair responses

open access: yesFrontiers in Immunology
IntroductionExacerbations of chronic obstructive pulmonary disease (COPD) increase mortality risk and can lead to accelerated loss of lung function. The increased inflammatory response during exacerbations contributes to worsening of airflow limitation ...
Rosa K. Kortekaas   +12 more
doaj   +1 more source

Profile of carcinogenic polycyclic aromatic hydrocarbons in relation with smoking status in COPD patients

open access: gold, 2023
Antigona Trofor   +5 more
openalex   +1 more source

COPD & COVID-19

open access: yesArchivos de Bronconeumología, 2021
Halpin, David M.G.   +2 more
openaire   +3 more sources

Comorbidity profiles in chronic obstructive pulmonary disease: a multicohort study

open access: yesERJ Open Research
Background Comorbidities are common in COPD, adversely affecting patients’ health. Cluster analysis has been proposed to study phenotypic variability, but inconsistent results have raised concerns.
Line Egerod   +9 more
doaj   +1 more source

Comment on “Computed Tomography Imaging Findings in Chemical Warfare Victims with Pulmonary Complications” [PDF]

open access: yesJournal of Cardio-Thoracic Medicine, 2013
Dr.Mirsadraei and colleagues performed an interesting study about the lung HRCT findings in chemical warfare patients who suffering from long-term pulmonary complications. They found that air trapping and mosaic attenuation were the most common lung HRCT
Shahrzad M.Lari
doaj  

Glucagon‐Like Peptide‐1 Receptor Agonists, Sodium‐Glucose Cotransporter‐2 Inhibitors, and Risk of Autoimmune Rheumatic Diseases

open access: yesArthritis &Rheumatology, Accepted Article.
Objective GLP‐1 receptor agonists (GLP‐1RAs) and SGLT2 inhibitors (SGLT2is) facilitate weight loss and exhibit immunomodulatory effects, but their impact on the risk of developing autoimmune rheumatic diseases (ARDs) is unclear. We compared ARD incidence following initiation of GLP‐1RAs, or SGLT2is, vs.
Derin Karacabeyli   +4 more
wiley   +1 more source

No evidence for additional systemic eosinophil mobilization during exacerbations in patients with COPD and chronic bronchitis but no allergy

open access: yesFrontiers in Medicine
BackgroundThere is published evidence that a modest increase in blood eosinophils during stable COPD indicates future risk for exacerbations and a potential utility of inhaled corticosteroids. This has been perceived as an argument for targeting systemic
Anders Andersson   +8 more
doaj   +1 more source

Comprehensive Care Management in Conjunction with Sputum Cytometry-Guided Pharmacotherapy in a Post-Discharge Clinic for Patients with COPD [PDF]

open access: bronze, 2021
Terence Ho   +13 more
openalex   +1 more source

Human vs. artificial intelligence: Physicians outperform ChatGPT in real‐world pharmacotherapy counselling

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims To assess the utility of the artificial intelligence (AI) chatbot ChatGPT (openly available version 3.5) in responding to real‐world pharmacotherapeutic queries from healthcare professionals. Methods Three independent and blinded evaluators with different levels of medical expertise and professional experience (beginner, advanced, and expert ...
Benjamin Krichevsky   +9 more
wiley   +1 more source

Triple therapy (ICS/LABA/LAMA) in COPD: thinking out of the box

open access: yesERJ Open Research, 2019
Lowie E.G.W. Vanfleteren   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy